Evidence map›Paper›PMID 31431887›Full record

ArticleCase reports in women's health2019

"Holidays" for osteoporosis drugs: A case-based approach.

Panagiotis Anagnostis, Stavroula A Paschou, Eustathios Kenanidis, Irene Lambrinoudaki, Michael Potoupnis, Eleftherios Tsiridis, Dimitrios G Goulis

Open access · goldAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in women's health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Panagiotis AnagnostisUnit of Reproductive Endocrinology, First Department of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki, Greece.
Stavroula A PaschouSecond Department of Obstetrics and Gynaecology, Medical School, National and Kapodistrian University of Athens, Greece.
Eustathios KenanidisCenter of Orthopaedic and Regenerative Medicine Research (CORE), Centre for Interdisciplinary Research and Innovation (CIRI), Aristotle University of Thessaloniki, Thessaloniki, Greece.
Irene LambrinoudakiSecond Department of Obstetrics and Gynaecology, Medical School, National and Kapodistrian University of Athens, Greece.
Michael PotoupnisCenter of Orthopaedic and Regenerative Medicine Research (CORE), Centre for Interdisciplinary Research and Innovation (CIRI), Aristotle University of Thessaloniki, Thessaloniki, Greece.
Eleftherios TsiridisCenter of Orthopaedic and Regenerative Medicine Research (CORE), Centre for Interdisciplinary Research and Innovation (CIRI), Aristotle University of Thessaloniki, Thessaloniki, Greece.
Dimitrios G GoulisUnit of Reproductive Endocrinology, First Department of Obstetrics and Gynaecology, Medical School, Aristotle University of Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRNational and Kapodistrian University of Athens · GRPapageorgiou General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•A "drug holiday" can be considered for patients at low fracture risk•It is optimal after completion of five years of alendronate and three years of zoledronic acid or risedronate use•The "drug holiday" strategy should not be implemented for denosumab, estrogen, SERMs or teriparatide.

Indexed as

AlendronateBisphosphonatesDenosumabDrug holidaysOsteoporosis

Identifiers

PMID31431887
PMCPMC6580330
OpenAlexW2952120705

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.